Dimitrios A. Garyfallos
London, ENG WC1E6DD, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.
Journal: Immunity
Published: May 30, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.
Journal: Immunity
Published: June 26, 2023
Immunization with Genetically Modified Trypanosomes Provides Protection against Transmissible Spongiform Encephalopathies.
Journal: International journal of molecular sciences
Published: August 16, 2022
Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.
Journal: Nature genetics
Published: June 14, 2022
METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation.
Journal: Molecular cell
Published: May 27, 2020
TRAF3 can interact with GMEB1 and modulate its anti-apoptotic function.
Journal: Journal of biological research (Thessalonike, Greece)
Published: April 01, 2020
Genome-Scale CRISPRa Screen Identifies Novel Factors for Cellular Reprogramming.
Journal: Stem cell reports
Published: August 28, 2018
UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.
Journal: Nature genetics
Published: November 28, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026